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Abstract 
 Insulin has an important role in cognition, in addition to its well-known functions 
in peripheral glucose metabolism. Impaired insulin signaling has been linked to the 
cognitive decline seen in type 2 diabetes and Alzheimer’s Disease (de la Monte & 
Wands, 2008). This study examined the effect of insulin on fMRI brain activation during 
working memory and episodic memory tasks in six postmenopausal women. The goal of 
this study was to understand how the hormonal change after menopause modifies insulin 
signaling and how this subsequently impacts fMRI brain activation and cognition. 
Subjects were tested under conditions of high peripheral insulin levels compared to low 
levels on two separate study days; these levels were manipulated by ingestion of glucose 
or water on either study day. We found that high peripheral insulin levels resulted in 
increased brain activation in both the working memory and episodic memory tasks. 
Results from this study suggest that insulin functionally changes cognitive processes in 
the brain in postmenopausal women, however further research is needed in order to 
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Introduction 
The role of insulin in the brain has become an important area of research over the 
last several years. While insulin is known for regulating glucose levels in the body, it has 
been shown to have a variety of functions in the brain as well (Plum et al., 2005). Insulin 
research has become especially prominent due to the increasing evidence that impaired 
insulin signaling in the brain is related to the cognitive decline that is seen in both 
Alzheimer’s Disease (AD) (Candeias et al., 2012) and type 2 diabetes (Kim & Feldman, 
2015). The importance of understanding mechanisms of insulin action in the brain is vital 
to our understanding of healthy cognitive processing in the central nervous system 
(CNS).   
 Plasma glucose concentration in the periphery is regulated by insulin, which 
maintains optimal physiological levels of glucose to provide energy for cellular metabolic 
processes. The role of insulin is to lower blood glucose concentrations. To do this, insulin 
molecule binds to an insulin receptor on a cell and signals the insulin-sensitive glucose 
transporter within the cell to move to the membrane of insulin-sensitive peripheral tissue 
(Saltiel & Kahn, 2001). The presence of the glucose transporter on these insulin-sensitive 
peripheral tissues allows for glucose uptake to occur from blood into the tissues. In the 
postprandial state, insulin concentration in the blood increases in order to control a rise in 
blood glucose levels (Aronoff et al., 2004).  
 A common test to evaluate the integrity of glucose metabolism and insulin 
signaling in the periphery is known as the oral glucose tolerance test (OGTT) (Stumvoll 
et al., 2000). In this test, an individual will have their fasting glucose level measured and 
they will subsequently drink a solution containing 75 mg of glucose. The physiological 
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response to this is measured through periodic blood samples measuring glucose and 
insulin levels over the course of two to three hours. In healthy individuals who complete 
an OGTT, glucose and insulin levels peak at 60 minutes after drink ingestion (Matsuda & 
DeFronzo, 1999). The OGTT has been a tool to evaluate for diabetes or impaired insulin 
sensitivity, which can be seen if blood glucose levels remain elevated throughout the 
duration of the test.  
 While the OGTT allows us to observe the direct relationship between insulin and 
glucose in the periphery, the role of insulin in the brain is more complicated. In fact, 
studies have shown that insulin has little to do with glucose metabolism in the brain 
(Seaquist et al., 2001). Early studies assessing the effects of peripheral insulin showed 
that increasing peripheral insulin levels had no effect on glucose transport across the 
blood brain barrier (BBB) in both animal models (Hom et al., 1984) and in human 
(Hasselbalch et al., 1999). However, peripheral insulin concentrations have been 
correlated with insulin levels in cerebrospinal fluid (CSF), providing evidence that insulin 
crosses the BBB (Plata-Salaman, 1991) and has significant effects on the CNS (Levin & 
Sherwin, 2011) even though it does not significantly change glucose metabolism. It has 
been established that the brain is less insulin-sensitive than peripheral tissues and glucose 
concentrations in the brain are regulated by other mechanisms (Blazquez et al., 2014).  
 While insulin may not have a significant impact on glucose metabolism in the 
CNS as it does in the periphery, it does have many critical roles in the brain that are vital 
for healthy functioning.  Insulin is known to be a potent neuroprotective agent (Blazquez 
et al., 2014) against apoptosis, oxidative stress, beta amyloid plaques, and ischemia.  
Many studies have shown that amyloid beta plaques, which are found in high 
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concentrations in the brains of AD patients and accumulate in the synapse to inhibit 
neuronal communication (Ferreira & Klein, 2011), bind to hippocampal neurons and 
trigger the removal of insulin receptors from the plasma membrane (De Felice et al., 
2009).  The change in insulin signaling in these AD patients may play a key role in 
cognitive impairment.  Insulin also modulates neuronal excitability, including regulation 
of potassium and calcium dependent ATP channels (Plum et al., 2005). Cumulatively, the 
neuromodulatory and neuroprotective effects that insulin has on the brain are vital to 
healthy brain functioning, and disruptions in insulin can cause significant neuronal 
abnormalities.  
 Insulin resistance, which is the diminished ability for cells to respond normally to 
insulin, has been implicated as a possible reason for the cognitive impairments seen in 
both type 2 diabetes and AD. Longitudinal studies have shown that people with type 2 
diabetes, a disease which is characterized by insulin resistance, are at a higher risk to 
develop AD and vascular dementia (Allen et al., 2004), and that this risk is almost 
doubled compared to healthy individuals (Yaffe et al., 2004). Alzheimer’s disease has 
come to be known in some realms as a “type 3 diabetes” due to the pathophysiological 
similarities in impaired insulin signaling in the CNS which has been seen in both diabetes 
and AD (de la Monte & Wands, 2008). In fact, insulin nasal spray is a novel therapy for 
AD patients and has been shown to improve performance in attention and memory tasks 
(Holscher, 2014).  
 In addition to type 2 diabetes and AD, changes in insulin signaling are also seen 
during menopause.  Menopause is one of the most drastic hormonal changes a woman 
undergoes in her lifetime, and such a decline in estrogen levels can have significant 
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effects on both physical and mental health. Menopause is known to cause metabolic 
changes, including increased central adiposity, dyslipidemia, and metabolic syndrome 
(MetS) (Gupte et al., 2015). In addition to physical changes, the menopause transition can 
also play a critical role in cognitive aging for women (Henderson, 2008). Some women 
experience noticeable changes in memory and other cognitive measures while other 
women seem to be unaffected. It is important to understand modifiable individual 
difference factors that contribute to these experiences during and after menopause. One 
of these factors may be insulin signaling. Jones et al. (2000) studied how estrogen levels 
in the body affect insulin signaling by studying mice that lack the enzyme to create 
estrogen, and they showed that these mice developed altered insulin signaling within the 
first year of life. Studies with human subjects have shown similar results; Pentti et al. 
(2009) showed that hormone therapy (HT) in postmenopausal women decreased the risk 
of developing type 2 diabetes. Both of these studies indicate that estrogen likely has a 
modulatory role in insulin signaling.  
 One target area in the brain for insulin is the hippocampus. Zhao et al. (1999) 
showed an increase in expression of insulin receptors in the hippocampus after training in 
a spatial memory tasks in rodent models. McNay et al. (2010) revealed that insulin is 
necessary for optimal cognitive functioning after seeing that injection of 
intrahippocampal insulin in rats acutely improved performance in spatial memory tasks, 
and intrahippocampal injection of a selective blockade for insulin acutely impaired 
memory performance in these same tasks.  In human models, intranasal insulin has been 
shown to improve declarative memory performance which is supported by normal 
hippocampal functioning in healthy subjects (Benedict et al., 2004) as well people 
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suffering from type 2 diabetes (Novak et al., 2014) and AD (Holscher, 2014). While it is 
evident that functionality of the hippocampus is regulated to some degree by insulin, 
insulin is also found in the brain throughout the cerebral cortex and cerebellum (Hopkins 
& Williams, 1997). Interestingly, the hippocampus has been shown to be an area of the 
brain that is affected by estrogen and menopause. Maki and Resnick (2000) showed that 
estrogen therapy (ET) in postmenopausal women over the course of two years was 
related to increased brain activation in the hippocampus, parahippocampal gyrus, and 
temporal lobe and better performance on standard neuropsychological memory tests 
compared to women not taking ET. The link between the role that insulin and estrogen 
have on the hippocampus is further evidence to suggest the link between these two 
hormones.   
 Studies above outline the improvement in cognitive performance seen after 
insulin administration in a variety of tasks in both healthy and unhealthy animal and 
human models.  Few studies have assessed how these changes in cognitive performance 
are functionally represented in the brain through imaging techniques. Studies that have 
utilized brain imaging to assess the effect of insulin on activation and metabolism have 
mostly been assessing the resting state activity of the brain (Chen et al., 2014) or activity 
in the hypothalamus after presentation of food –related stimuli (Kullmann et al., 2015). 
Additionally, functional magnetic resonance imaging (fMRI) to assess brain activation 
during cognitive tasks has been utilized to examine the acute effects of glucose on 
cognition (e.g. Schopf et al., 2013) but no study to date has examined the effect of insulin 
on brain activation when subjects are challenged with a cognitive task. This study 
explored how insulin affects brain activation during cognitive tasks that assess working 
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memory and episodic memory. This study was intended to examine the effect of insulin 
signaling on women after menopause. As previously described, studies have shown 
estrogen modulates insulin response and sensitivity, and decreased circulating estrogen 
levels is linked to altered insulin signaling and sensitivity in the periphery (Jones et al., 
2000). For this reason, the current study only included postmenopausal women and future 
studies will assess the same measures in pre-menopausal women.  
We manipulated insulin levels in participants by having them ingest a glucose 
drink (OGTT) compared to an equivalent volume of water (mock OGTT) on two separate 
study days. We tested the hypothesis that women would have improved performance on 
working memory and episodic memory tests for the OGTT day compared to the mock 
OGTT day due to higher levels of insulin in the body. We further hypothesized that we 
would observe changes in brain activation during fMRI tasks.  For the working memory 
task in this study, decreased activation in the brain, particularly in the prefrontal cortex,  
has been related to more efficient thinking patterns (Neubauer & Fink, 2009) and thus 
decreased activation would indicate better performance. We hypothesized decreased 
frontal activation in the glucose condition compared to the mock condition. For the 
episodic memory task used in this study, increased activation in the hippocampus was 
previously associated with improved performance (Kirwan & Stark, 2004), and thus we 
anticipated increased hippocampal activation in the glucose compared to mock condition.    
Methods 
Participants  
Participants were six cognitively normal postmenopausal women, aged 54-59, 
M(SD)= 56(3.0) (see Table 1 for demographic information). Women were recruited by 
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calling past research subjects in the Clinical Neuroscience Research Unit and by posting 
advertisements in the community within a 20 mile radius of UVM, as well as using online 
advertising through UVM.  In total, 42 women responded to these advertisements. 
Women underwent a medical screening over the phone to ensure they were a proper fit 
for the study. Thirty women were screened over the phone. Inclusion comprised women 
aged 50-60, postmenopausal (defined by absence of menstruation for at least one year) 
and without any significant medical conditions. Women were excluded if they were 
currently taking supplemental estrogen or taking any CNS-acting drug, such as anti-
depressants or anti-anxiety medications. Medical exclusion criteria included diabetes or 
impaired insulin signaling, chronic obstructive pulmonary disease, coronary artery 
disease, cancer, anxiety, and depression.   Medication use by women in this study was as 
follows: one woman was taking levothyroxine for hypothyroidism, one woman was 
taking glucosamine for arthritic pain, and one woman was taking naproxen for headaches.  
Once each woman passed this phone screening, they were scheduled for an in-person 
screening visit at the University of Vermont (UVM) Clinical Research Center (CRC).  
Screening Visit 
All participants arrived to the CRC between 7am and 9am having fasted since 
midnight the night before.  After signing informed consent, participants had baseline vital 
signs (respiratory rate, temperature, blood pressure, and heart rate) taken.  Laboratory 
results were drawn which measured hormone (estradiol, follicule-stimulating hormone, 
and insulin) and glucose levels. Women were considered postmenopausal if they had not 
had a menstruation in one year, estradiol levels were less than 50 pg/ml, and FSH levels 
were greater than >30 IU/L. Insulin resistance was measured using the Homeostatic 
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Model Assessment (HOMA) scale, which uses fasting glucose and insulin levels to 
determine how efficiently the body can maintain a normal and steady amount of glucose 
in the blood (Mojiminiyi & Abdella, 2010). HOMA score values of less than 1.4 were 
considered acceptable for this study, as is standard for the HOMA-2 calculator that was 
used to calculate scores (Mojiminiyi & Abdella, 2010). Women were screened for MRI 
suitability to ensure they had no metal in their body that could cause harm to the patient 
in the scanner. Seven women were screened for this study and one woman was excluded 
due to self-reported poor tolerance to fasting. All other women met the above outlined 
criteria.  
Cognitive Screening 
Participants were cognitively evaluated using the Mini Mental State Exam 
(MMSE; (Folstein et al., 1975) and the Brief Cognitive Rating Scale (Reisberg & Ferris, 
1988), as well as the Global Deterioration Scale  (GDS) which rated the degree of 
cognitive impairment (Reisburg et al., 1993). On the MMSE a higher score was related to 
greater global cognitive functioning. On the BCRS and GDS, a higher score was related 
to a greater degree of cognitive impairment. Participants were required to have a MMSE 
score greater than or equal to 27 and a GDS score of 1 or 2.  All women met these 
criteria.  
Behavioral screening 
Behavioral screening involved a partial Structured Clinical Interview for DSM-
IV-TR (SCID;(First et al., 2001)) to establish the presence/absence of current or past 
major depressive disorder (MDD), current mania, or current dysthymia. In addition, 
participants completed the Beck Depression Inventory (BDI-II) (Beck et al., 1996) and 
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Beck Anxiety Inventory (BAI) (Beck & Steer, 1990). A cut off score of 10 was used for 
the BDI and 15 for the BAI. All women met these behavioral screening criteria.  
Lifetime Hormone Exposure Questionnaires 
Each subject answered a series of questions about lifetime hormone exposure 
regarding menstrual cycle history, motherhood, menopause and history of HT (Lord et 
al., 2009). Menstrual cycle history included questions about age at menarche, 
amenorrhea, and contraceptive hormone use. Information about motherhood regarded 
questions surrounding number of pregnancies, miscarriages, and length of time spend 
breastfeeding. Inquiries into the subject’s menopause history included age at menopause 
and whether this transition was natural or surgically induced. Finally the questionnaire 
assessed hormonal therapy use after menopause, including type, duration, and age of use.  
Study Visits  
After passing the medical, psychological, and behavioral screening measures, 
participants came to the UVM CRC for two study days.  Upon arriving at the CRC 
participants had baseline vitals drawn and a plastic catheter was subsequently placed in 
their arm. Each visit involved an oral glucose tolerance test (OGTT), where the subject 
ingested a drink containing 75 mg of water, or a mock OGTT where the subject ingested 
an equivalent volume of water. The study was a single-blind design with the 
experimenter and nursing staff being blinded to the drink consumption on each study day. 
A timer was started immediately after the participant finished her drink. Shortly after 
subjects completed the OGTT or mock drink, they were escorted to the MRI facility in a 
wheelchair where functional images were taken when subjects completed tasks assessing 
working memory and episodic memory. Functional tasks in the MRI scanner were timed 
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so that they would begin 60 minutes after the participant had finished the drink so that  
insulin response was maximal. After the fMRI session, which took approximately 60 
minutes, participants completed two cognitive tasks and a series of questionnaires 
assessing mood and physical comfort. 
fMRI Tasks  
N-back Task 
The N-back Task was used as a measure of verbal working memory. In this task, 
the subject viewed a string of consonant letters (except L, W, and Y), one every three 
seconds. Four conditions were presented: 0-back, 1-back, 2-back and 3-back. In each of 
the 1-back, 2-back, and 3-back conditions, the task was to decide whether the currently 
presented letter matched the letter that had been presented 1, 2, or 3-back in the sequence. 
The subjects were asked to press the “match” button when the letter on the screen 
matched the letter for the certain conditions, and the “mismatch” button for every other 
letter. In the 0-back condition, the subject was given a target letter and she made a 
“match” response when that target appeared. In the one-back condition, the goal was to 
press the match button when a letter matched the letter that appeared just prior (the letter 
appearing one item back). In the two-back condition, the match occurred when a letter 
was identical to the letter two items back. In the three-back condition, a match occurred 
when a letter was identical to the letter that appeared three items back. Participants were 
given two trial rounds of each condition on a computer before completing the full N-back 
task in the MRI scanner In the scanner, the 0-, 1-, 2-, and 3-back conditions were 
repeated three times in a counterbalanced order so that the same condition wouldn’t 
appear twice in a row. This was a block design task where participants responded to nine 
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items in a block of 27 seconds, with a rest break following each block with a plus sign (+) 
fixation for 12 seconds. The total time of this task was 8 minutes and 12 seconds. 
Accuracy measures and reaction times were automatically recorded for each trial.  
Different versions of this task were used on separate study days and the sets were 
counterbalanced across study days. 
Participants responded to all items by button press through an MRI compatible fiber 
optic button response system (Psychology Software Tools, Pittsburgh, PA) to indicate 
whether the letter was a match or mismatch. Stimuli were delivered through an MR-safe 
computer monitor. Experimental tasks were programmed using the E-prime software 
package and presented by PC; the PC recorded participant responses.   
Face-Name Encoding Task  
Prior to entering the MRI scanner, subjects were shown two unfamiliar pictures 
with fictional names associated with each picture.  The fMRI task used these pictures, 
which were deemed “familiar” pictures because the participant had been previously 
introduced to the face-name pair, as well as new face-name associations, which the 
participant had never seen before. These pictures were part of the “novel” condition, 
because the participants had not been previously introduced to these stimuli.  For each 
face-name pair, subjects were instructed to press the match button if they believed the 
fictional name below the photograph “fit” the face. They were told this was a totally 
subjective decision.  They were asked not to make a response if the fictional name did not 
“fit” with the picture presented.  This was a block-design task which lasted approximately 
six minutes, with alternating 40-second blocks of novel and familiar faces. After the 
scanning session finished, subjects were given a computer task with the same faces 
Running	  Head:	  INSULIN	  AND	  BRAIN	  FUNCTIONING	  	  	   14	  
appearing one at a time on the screen, with two names. Subjects were asked to identify 
which name was paired with this face during the MRI scan. The computer automatically 
recorded reaction times and accuracy measures. Different sets of faces were used for each 
woman’s study day and the sets were counterbalanced across days. 
fMRI Scan Procedure 
All participants were scanned on a Philips 3T Achieva d-Stream scanner and 
received the following MR sequences as part of the imaging protocol: (1) A sagittal T1-
weighted spoiled gradient volumetric sequence oriented perpendicular to the anterior 
commissure (AC)-posterior commissure (PC) plane using a repetition time (TR) of 9.9 
ms, echo time (TE) of 4.6 ms, flip angle of 8 degrees, number signal averages (NSA) 1, 
field of view (FOV) of 256 mm, 256 X 256 matrix, and 1 mm slice thickness with no gap 
for 160 contiguous slices. (2) An axial T2-weighted gradient spin echo (GRASE) 
sequence using the AC-PC line for slice positioning. Twenty-eight contiguous slices 5 
mm thick and no gap were acquired using TR 2466 ms, TE 80 ms, NSA 3 and FOV of 
230 mm. All images were reviewed by a board-certified neuroradiologist to exclude 
intracranial pathology. fMRI was performed using EpiBOLD (echoplanar blood 
oxygenation level dependent) imaging using a single-shot sequence (TR 2500 ms, TE 35 
ms, flip angle 90 degrees, 1 NSA for 197 volumes). Resolution was 2.5 mm x 2.8 mm x 4 
mm. Thirty-four contiguous slices 4 mm thick with no gap were obtained in the axial 
oblique plane parallel to the AC-PC plane using a FOV of 240 mm and a matrix size of 
128 x 96. Field map correction for magnetic inhomogeneities was accomplished by 
acquiring images with offset TE at the end of the functional series.  
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Episodic Memory Buschke Selective Reminding Test (SRT) 
After the MRI, participants completed the Buschke SRT as a measure of episodic 
memory (Buschke & Fuld, 1974). The SRT is a multi-trial verbal list-learning task 
allowing the examination of acquisition, encoding, and retrieval. This standard test offers 
measures of storage into and retrieval from memory. For this task, a list of 16 unrelated 
words was read aloud to the subject. The subject recalled as many words as possible. 
Then, the person administering the task would selectively remind the subject of the words 
that she did not recall, and asked her to try to recall the list of 16 words again in any 
order. There were eight trials in this task. In addition, there was one delayed recall trial 
that was administered about 20 to 30 minutes after the end of the eighth trial. The total 
recall was the total amount of words the subject recalled from all eight trials. Consistency 
occurred when the subject remembered a word in succession for two trials. Intrusions 
were words the subject recalled not on the specified list. Recall failure occurred when the 
subject failed to remember a word on two consecutive trials. Totals among these 
variables in all trials were added to give total recall, total consistency, total recall failure, 
total intrusions, and delayed recall. 
Letter Number Sequencing Task  
The Letter-Number Sequencing task (Wechsler, 1987)  is a measure of verbal 
working memory. In this task, a series of letters and numbers is read aloud to the subject 
and they are asked to repeat them back by saying the numbers first in order and then the 
letters in alphabetical order. The subject can attempt to complete three trials of equal 
difficulty. If the subject repeats back one of these trials accurately, the experimenter 
moves on to the next sequence which is of greater difficulty.  If the subject fails to 
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accurately repeat back any of the three sequences of equal difficulty correctly, the task is 
finished. Difficulty is characterized by the number of letters or numbers in each trial, with 
more items representing a greater working memory load.  
Mood and Physical Symptoms  
After the cognitive battery was completed, participants completed the Profile of 
Mood States (POMS) (McNair et al., 1971) as well as the Stanford Sleepiness Scale 
(Hoddes et al., 1973), Subjective Visual Analogue Scale (SVAS; (Newhouse et al., 
1994)), and a Physical Symptom Checklist (PSCL).  The experimenter completed the 
Brief Psychiatric Rating Scale (BPRS; (Overall & Gorham, 1962)) and Objective Visual 
Analogue Scale (OVAS; (Newhouse et al., 1994)). The IV catheter was removed after the 
120’ blood sample was drawn, and the participants were given lunch prior to leaving. 
Participants left the CRC after the nurses ensured that they felt physically at baseline.  
fMRI Analyses  
For the N-back task, statistical analyses were performed using a 2(Drink: 
Glucose, Water) X 2(Working Memory Load: 0- back 2-back) random effects ANOVA 
using standard ANOVA procedures in Brain Voyager (Brain Voyager QX, The 
Netherlands).  In an effort to correct for multiple comparisons we used a cluster-level 
correction by utilizing the cluster-level statistical threshold estimator from Brain Voyager 
QX to estimate a minimum cluster size threshold based on the approach of Forman and 
colleagues (Forman et al., 1995).This procedure estimated a minimum cluster size of 27 
voxels in functional space (3x3x3) at an alpha level of 0.05 for the fMRI analyses.  
 For the Face-Name Encoding task, statistical analyses were performed using a 
2(Drink: Glucose, Water) by 2(Recognition: Novel, Familiar) random effects ANOVA 
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using standard ANOVA procedures in Brain Voyager (Brain Boyager, QX, The 
Netherlands). The same cluster-level correction described above was used to correct for 
multiple comparisons in this task. This procedure estimated a minimum cluster size of 29 
voxels in functional space (3x3x3) at an alpha level of 0.05 for the fMRI analyses. 
Results 
Activation Data: Working Memory 
First, we examined working-memory related brain activation in the N-back task to 
demonstrate the expected task effects on the mock day (Figure 1).  As expected, greater 
activation was seen in the bilateral frontal, parietal, and cerebellar regions with greater 
working memory load  (the 2-back condition minus the 0-back condition) on the mock 
day (Cohen et al., 1997).   
Second, we examined the effect of increased working memory load on brain 
activation in the OGTT compared to the mock day. This contrast examined the effect of 
high physiological levels of insulin on working memory and brain activation compared to 
low insulin levels.  We specifically examined the effect of the OGTT minus the mock day 
in the 2-back minus 0-back condition, as is commonly done using this task (Cohen et al., 
1997) to assess the difference between activation for greater working memory loads on 
the two separate study days. For this comparison, greater activation was seen for the 
OGTT compared to the mock drink (Figure 2). This increased activation was specifically 
seen in the inferior parietal lobe bilaterally (BA 40) (Table 2).  
Activation Data: Episodic Memory 
 First, we examined episodic-memory related brain activation in the Face-Name 
encoding task to demonstrate the expected task effects on the mock day (Figure 3). As 
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expected, bilateral hippocampal activation was seen in the novel compared to the familiar 
faces condition on the mock day (R. Sperling et al., 2003) along with a diffuse episodic 
encoding network.  
Second, we assessed activation in the novel versus familiar facial presentations on 
the OGTT day compared to the mock day to examine the effect of insulin on brain 
activation during the episodic memory task. We specifically examined the effect of 
OGTT minus the mock day in the novel condition minus the familiar condition and found 
increased activation in the brain (Figure 4).  There were many regions that showed 
increased activation in this task (Table 3) mostly on the left side of the brain, as well as 
the bilateral cingulate gyrus, medial temporal gyrus, and frontal gyrus.  
Working Memory Performance  
 Data were analyzed with a 2(Drink: Glucose, Water) X 2(Working Memory Load: 
0-back, 2-back) mixed model ANOVA for the proportion correct and proportion of false 
alarms (Figures 5 and 6). Drink and working memory load were within-subject factors.  
There was a significant effect on working memory load on proportion correct 
(F(1,5)=30.625, p=0.003) and proportion of false alarms (F(3,15)=.14.45, p<0.001). 
There was no main effect or interaction involving the glucose or water condition OGTT 
or mock condition on N-back performance.  
Episodic Memory Performance  
 Reaction time and accuracy measures were analyzed for the face-name encoding 
task (Table 4). There were no significant differences between these measures for the 
OGTT day compared to the mock day for either accuracy or RT (ps>0.12). 
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Behavioral Measures 
On each study day, participants completed the POMS, the PSCL, Stanford 
Sleepiness Scale, and the SVAS as subjective measures of current mood and physical 
symptoms. The experimenter completed the BPRS and OVAS as objective psychiatric 
and physical symptom measures.  There were no significant differences between any 
subjective measures between study days (ps>0.08, smallest p value for the alertness 
measure on the SVAS) (Tables 5-7). There were no significant differences between any 
objective measures between study days (ps>0.11, smallest p value for the sweat measure 
in the OVAS) (Table 8). 
Cognitive Measures  
 For the Buschke SRT, there was a significant difference in the total recall failure 
measure of the task which showed greater total recall failure on the OGTT day compared 
to the mock OGTT day (t(5)=2.59, p=0.048). This was consistent with the pattern of 
means from other measures of the Buschke SRT, where performance on the OGTT day 
was worse compared to the mock OGTT (Table 9) however these results were not 
significant (ps>0.12). There was no significant difference in performance between study 
days for the letter-number sequencing task (Table 9) (p>.50).  
Glucose and Insulin Measures   
Blood samples measuring glucose and insulin values were drawn at four time 
points throughout the study days: 0’ 30’, 60’, and 120’ minutes.  Data were analyzed with 
a 2(Drink: OGTT or mock drink) X 4 (Time: 0, 30 , 60, 120 minutes) mixed model 
ANOVA  for glucose levels.  Drink and time were within subject factors.  There was no 
main effect of drink on glucose levels (F(1,5)=1.681, p=0.251). There was no main effect 
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of time on glucose (F(3,15)= 1.245, p=0.329), nor was there an interaction between drink 
and time over the course 120 minutes (F(3,15)=0.621, p=0.612) (Figure 7).  
Insulin levels were analyzed with a 2 (Drink: OGTT or mock) X 4(Time: 0, 30, 
60, 120 minutes) mixed model ANOVA. Drink and time were both within subject factors. 
There was a main effect of drink (F(1,5)=18.4, p=0.008) and time (F(3,15)=8.443, 
p=0.002). There was a significant interaction between drink and time (F(3,15)=7.554, 
p=0.003). To further probe this interaction, we assessed differences for each time point 
on both study days. Insulin levels were significantly greater at the 30’ (t(5)=4.96, 
p=0.004), 60’ (t(5)=3.41, p=0.018), and 120’ (t(5)=2.93, p=0.03) time points on the 
OGTT day compered to the mock day.  As expected, insulin levels were not significantly 
different at the zero minutes, which was prior to drink ingestion (t(5)=1.48, p=0.20) 
(Figure 8).  
Vital Signs  
 There were no significant differences in systolic blood pressure (t(4)=1.88 
p=0.13), diastolic blood pressure (t(4)=1.5, p=0.21), respiratory rate (t(4)=0.61, p=0.57), 
pulse (t(4)=0.80, p=0.46), or temperature (t(4)=0.14, p=.89) between study days (Table 
10).   
Discussion 
The current study was the first to examine the effect of peripheral insulin levels 
on brain activation during cognitive tasks.  Results showed that varying insulin levels 
does change brain activation in both the N-back task and the face-name encoding task, 
which assessed working and episodic memory, respectively. We tested the hypothesis 
that peripheral insulin levels would change fMRI activation for working memory and 
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episodic memory tasks in postmenopausal women. For the N-back, decreased activation 
was expected in the prefrontal cortex with improved performance on the tasks.  For the 
face-name encoding task, we hypothesized that increased hippocampal activation would 
be observed as well as better recognition memory performance after the scan. Our data 
did not support these hypotheses. In the N-back task, greater activation on the OGTT day 
compared to the mock day was seen in the inferior parietal lobe bilaterally for the 2-back 
condition compared to the 0-back condition. The inferior parietal lobe has been 
implicated in retrieval during working memory tasks (Berryhill & Olson, 2008). As 
previously discussed, prior neuroimaging studies have shown that increased activation in 
areas implicated in working memory is associated with less efficient thinking patterns 
(Neubauer & Fink, 2009). This was consistent with N-back performance data trends; 
participants had the poorest performance measures on the 2-back compared to other 
conditions on the OGTT day compared to the mock day (see Figures 5 and 6). Both the 
imaging and performance data indicate a negative effect of high peripheral insulin on the 
brain and cognition. It should be noted that we did not compare the 3-back minus the 0-
back condition due to prior literature suggesting that performance is affected by mental 
fatigue in tasks which involve a high degree of working memory load, and that this 
mental fatigue is greater in the 3-back compared to the 2-back condition (Guastello et al., 
2015). 
Similar findings were seen with the face-name encoding task activation patterns. 
Studies have shown that successful encoding of face-name pairs is associated with greater 
activation in the brain, however this activation pattern is typically seen in the 
hippocampus  (Kirwan & Stark 2004; Sperling  et al., 2001). In this study, greater 
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activation on the OGTT day compared to the mock day was seen in the bilateral middle 
temporal gyri and many other regions of the brain (see Figure 4 and Table 3). The middle 
temporal gyri are areas of the brain that have been implicated in encoding tasks 
(Bernstein et al., 2002). However, increased activation on the OGTT day compared to the 
mock day was seen diffusely throughout the brain, more so in the frontal lobe of the left 
hemisphere compared to the right hemisphere. 
 Similar to the N-back task where greater activation is associated  with decreased 
neural efficiency (Neubauer & Fink, 2009), diffuse activation for encoding tasks has been 
negatively associated with task performance and positively associated with increased 
insulin resistance (Baker et al., 2011). Baker et al. (2011) showed that individuals with 
pre-diabetes or type 2 diabetes had greater and more diffuse activation on positron 
emission tomography (PET) imaging. Findings from Baker et al. (2011) suggest that 
increased peripheral insulin levels may impair cognition and increase brain activation 
compared to normal insulin levels, and these findings are consistent for both the N-back 
task and the face-name encoding task.  
It should be noted that greater activation in the left hemisphere for encoding 
processes is consistent with prior literature. Typically, different regions in the brain are 
implicated in memory encoding and retrieval processes. The hemispheric 
encoding/retrieval asymmetry (HERA) model has shown through a large set of functional 
neuroimaging studies that encoding processes typically occur in the left hemisphere and 
retrieval processes in the right hemisphere (Habib et al., 2003). The greater left-sided 
hemispheric activation seen on the OGTT day compared to the mock day in the encoding 
task is consistent with this HERA model, which suggests that peripheral insulin has a 
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modulatory role in encoding processes and activates brain regions involved in the 
episodic memory network.  
Ultimately, our results did not show anticipated activation patterns for either the 
working memory or the episodic memory task. Performance measures for working 
memory tasks were numerically worse on the OGTT day compared to the mock day. 
Performance measures for the episodic memory task were improved on the OGTT day 
compared to the mock day, however these measures are completed after the scan and 
represent retrieval success rather than encoding success.  
 Other cognitive measures in this study included the Buschke SRT (a measure of 
episodic memory) and the letter-number sequencing task (a measure of working memory) 
(see Table 9). While there were no significant differences in performance between study 
days for the letter-number task, there was a significantly greater recall failure for the 
OGTT day compared to the mock day.  This result was consistent with other performance 
measures on the Buschke SRT such as the total recall and total consistency; both 
measures showed decreased performance on the OGTT day compared to the mock day, 
however these results were not significant.  These trends do not align with previous data 
supporting improved cognitive performance on working memory tasks with higher 
physiological levels of insulin (Reger et al., 2008), however these improvements are 
typically seen with intranasal delivery rather than peripheral delivery of insulin.  
Studies showing cognitive improvement with intranasal insulin have not stratified 
results by gender, which may have a large role on insulin signaling in the brain. The role 
of gender in the context of circulating gonadal steroid levels is an important factor to 
consider in these studies that assess how cognition intranasal insulin sprays. The goal of 
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this study is to understand how estrogen modulates insulin signaling and cognition. Thus 
far, the only study to date examining the differential effect of intranasal insulin between 
men and women has assessed body fat, showing that intranasal insulin reduces body fat 
in men over the course of eight weeks, but not in women (all of whom were taking oral 
contraception) (Hallschmid et al., 2004). This study shows that intranasal insulin has 
different influences in men and women and we therefore may not be able to expect to see 
the same cognitive improvements in a sample of postmenopausal women that have been 
previously seen in both women and men.   
 The postmenopausal status of these women should be taken into account when 
considering the results from this study. Low circulating estradiol levels in 
postmenopausal women likely have an impact on these results. Additionally, based on 
responses from lifetime estrogen exposure questionnaire, only two women used HT after 
menopause and only continued it for a maximum of two weeks.  Based on prior research 
suggesting that estrogen is key for normal insulin signaling (Jones et al., 2000), one 
hypothesis for the activation data seen for both memory tasks is that there is not enough 
estrogen in the body to regulate even the higher physiologic doses of insulin seen in the 
OGTT day compared to the mock day.  Insulin may not be able to carry out optimal 
functioning in the brain due to low estrogen levels. 
Another hypothesis for our results is that perhaps the peripheral insulin increase 
was not large enough to have any significant cognitive implications on performance. 
While all peripheral insulin levels were significantly greater for the OGTT study day 
compared to the mock OGTT day, peripheral insulin levels are not always correlated with 
CNS levels (Havrankova et al., 1979) and these levels likely have different effects on 
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cognition, with high CNS levels providing cognitive improvement which can be seen 
based on the effectiveness of intranasal insulin spray in the context of AD  (Holscher, 
2014) and high peripheral levels relating to cognitive impairment seen in the context of 
insulin resistance (Pavlik et al., 2013). While none of the women who participated in this 
study were insulin resistant based on their HOMA-IR scores, perhaps the presence of 
higher than baseline insulin levels is enough to decrease cognitive performance measures. 
We hypothesize that this increased peripheral insulin may be another factor contributing 
to the negative effect that the brain activation in the OGTT compared to the mock day 
represents.  
The OGTT itself has acute effects in the body that may be detrimental to 
cognition. Choi et al. (2013) showed that glucose ingestion after an OGTT significantly 
increased peripheral inflammatory markers. Furthermore, acute peripheral inflammation 
decreases glucose metabolism particularly in the medial temporal lobe of the brain and 
significantly impairs performance on cognitive tasks, including spatial memory 
performance (Harrison et al., 2014). These studies suggest that there may be confounding 
factors related to manipulating insulin through the OGTT. The hippocampus plays a 
major role in both spatial and episodic memory (Burgess et al., 2002). Perhaps the 
increase in peripheral inflammation and decrease in glucose metabolism in the 
hippocampus causes suboptimal hippocampal functioning. This is one hypothesis for why 
there is no change in hippocampal activation for the face-name encoding task between 
study days. Furthermore, decreased hippocampal functioning could induce a 
compensatory response in the brain (Stern, 2002) which may lead to the diffuse increased 
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activation in the face-name encoding task seen on the OGTT day compared to the mock 
day. 
In conclusion, there are a variety of variables that may have influenced data 
gathered in this study. Our results indicate that high peripheral insulin levels in 
postmenopausal women negatively impacts fMRI brain activation during episodic 
memory and working memory tasks. This may be due to altered insulin signaling in these 
postmenopausal women because of low estrogen levels. It may also be a result of 
differences in insulin levels in the periphery versus the CNS, or the acute inflammation 
that has been shown to occur during OGTTs.  
Limitations 
 There are several limitations in this study to consider. One limitation in this study 
is the sample size was a total of six women.  A larger sample-size is needed to confirm 
the results of this study that they are not due to chance.  With a larger sample size, the 
statistical power would be greater.  
 A second limitation was the use of OGTT to increase peripheral insulin levels. An 
increase in insulin levels is a secondary effect of glucose ingestion, and other physiologic 
factors might affect rate and amount of insulin release for each participant. Insulin levels 
could be better controlled and monitored if participants were given an insulin infusion. 
Furthermore, peripheral insulin may not have a significant effect on CNS insulin and a 
more direct route of insulin administration to the CNS, such as intranasally, would be a 
more effective way to assess insulin response in the brain. There are some adverse effects 
to intranasal delivery, such as mild rhinitis, nosebleeds, and the risk of allergic reaction. 
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Thus, in order to minimize risk and assess how baseline physiologic insulin levels change 
cognition, the OGTT method was utilized in this study.   
Future Studies  
 This was a study that examined the interactive effect of estrogen and insulin on 
cognition.  A similar protocol should be completed in the future with premenopausal 
women in order to further understand the role of insulin in the brain and how estrogen 
may modulate its effects.  Additionally, other studies in the future assessing memory in 
the context of more controlled peripheral and CNS insulin manipulation may provide 
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Table 1. Demographic data and baseline fasting insulin/glucose levels (means and 


























Age (years) 56 (3.0) 
BMI 25.01 (3.0) 
Education (years) 17.66(2.88) 
Fasting Glucose Levels (mg/dl) 89.89 (6.26) 
Fasting Insulin Levels (uU/mL) 3.99 (0.86) 
HOMA-IR Score  0.50 (0.14) 
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Table 2. Effects of the OGTT compared to the mock drink in the 2-back minus the 0-back 
condition including Talairach coordinates, cluster size, region descriptions (Brodmann’s 
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Table 3. Effect of the OGTT compared to the mock drink in the novel faces minus the 
familiar faces including Talairach coordinates, cluster size, region descriptions 























48, -53, 5 9792 Right Middle Temporal 
Gyrus (BA 39) 
13.29 0.0004 
 37, 19, -0.39 2392 Right Insula  
(BA 13) 
10.61 0.0001 
 15, -58, 14 1851 Right Posterior Cingulate 
(BA 30) 
6.15 0.0016 
 1, 41, 37 788 Right Medial Frontal Gyrus 
(BA 8) 
5.32 0.0031 
 0.04, -59, 14 1868 Left Precuneus  
(BA 7) 
5.75 0.0022 
 -4, 24., 39 2321 Left Cingulate Gyrus  
(BA 32) 
6.38 0.0014 
 -9, -69, 15 1212 Left Cuneus (BA 18) 6.82 0.0010 
 -23, 51, -14 1216 Left Cerebellar Culmen 
 (BA N/A) 
5.19 0.0035 
 -21, -78, -12 860 Left Fusiform Gyrus 
 (BA 19) 
6.39 0.0014 
 -26, -3., -12 1249 Left Middle Frontal Gyrus  
(BA 6) 
4.61 0.0058 
 -29, -72, 32 824 Left Precuneus   
(BA 19) 
4.90 0.0044 
 -41, 20, -4. 2924 Left Inferior Frontal gyrus  
(BA 47) 
5.71 0.0023 
 -48, 4, 35 784 Left Precentral Gyrus  
(BA 6) 
7.22 0.0007 
 -55, -54, 6. 5289 Left Middle Temporal Gyrus 
(BA 39) 
8.30 0.0004 
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Table 4. Accuracy (proportion correct) and reaction time (ms) (mean and standard 
deviations) for the recognition memory of faces and names seen during the MRI task. 
There were no significant differences among these measures between study days 
(ps>0.12). 
 Mock  OGTT 
Accuracy 0.70 (0.062)  0.80(.080) 
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Table 5. Scores for POMS measures (means and standard deviations) for each study day. 
There were no significant differences among these measures between study days 
(ps>0.19, smallest p for the anger measure). 
 Mock OGTT 
Tension  1 (0.89) 1.5 (1.38) 
Depression 0(0) 0.83(2.04) 
Anger  0(0) 1.67(2.73) 
Vigor  20.83(7.46) 18 (7.77) 
Fatigue  1.83(2.64) 2 (2.60) 
Confusion 3.5 (2.59) 2.16(0.75) 
Total Mood 
Disturbance 
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Table 6. SVAS measurements (mm) of physical symptom and mood (means and standard 
deviations) for each study day. There were no significant differences among these 
measures between study days (ps>0.08, smallest p value for the alertness measure). 
 Mock OGTT 
Anxiety 2.33 (1.99) 8.75(9.57) 
Mood 77.83 (6.66) 79.91 (14) 
Alertness 80.58 (15.27) 69 (24.80) 
Comfort 29.33 (30.52) 37.75 (40.31) 
Fear 3.58 (3.90) 3.83 (1.94) 
Irritability  9.5 (8.54) 28.33 (39.97) 
Hunger  55.33 (19.94) 38.33 (17.78) 
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Table 7. Scores of the PSCL and Stanford Sleepiness Questionnaires (means and standard 
deviations) for each study day. There were no significant differences among these 
measures between study days (ps>0.24). 
 Mock  OGTT 
PSCL  5 (3.46) 3.17 (2.04) 
Stanford 
Sleepiness 
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Table 8. OVAS measurements (mm) and BPRS objective scores (means and standard 
deviations). There were no significant differences among these measures between study 
days (ps>0.11, smallest p value for the sweat measure). 
 Mock  OGTT 
Drowsiness 16.33(15.78) 18(8.34) 
Restlessness 0.66(1.17) 3.59(8.05) 




Euphoria 1 (2.44) 6 (14.21) 
Irritability 6.25 (2.23) 15.17(13.34) 
Sweating 0.83 (0.25) 0.58(0.80) 
GI Distress 0.17(0.25) 0.42(0.66) 
Incoordination 1.08(1.50) 2.33(5.71) 
Fatigue 32.75 (11.56) 26 (22.18) 
Depression 1.83(2.99) 4.91(5.29) 
Anxiety 15 (14.95) 24.16(24.28) 
Alertness 71.75 (8.80) 70.33 (7.43) 
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Table 9. Buschke SRT and the Letter-Number Sequencing scores (means and standard 
deviations) between study days. There was a significant difference in total recall failure 
between study days (t(5)=2.59, p=0.048). There were no significant differences among 
other measures between study days (p>0.55).  
 
 Mock  OGTT 
Total Recall 84.67(19.74) 81.67(12.84) 
Total Consistency 49.67 (24.94) 46.5 (17.34) 
Total Recall Failure 10.83 (10.62) 13.83 (9.33) 
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Table 10. Vital Signs measures (means and standard deviations) taken at the beginning of 
each study visit. There were no significant differences among these measures between 
study days (ps>0.21, smallest p for diastolic blood pressure). 
 Mock  OGTT 
Systolic BP (mm/Hg) 115.2 (18.69) 120.8(18.77) 
Diastolic BP (mm/Hg) 62.4 (9.31) 67.2(9.09) 
Pulse (beats/minute) 57.2 (8.07) 59 (13.36) 
Respiratory Rate (breaths/minute) 14.8(2.68) 16 (2.83) 
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Figure Legends 
 
Figure 1. Activation map for the N-back task comparing the 2-back minus the 0-back on 
the mock day only.  
Figure 2. Activation map for the N-back task comparing the 2-back minus the 0-back  
minus on the OGTT day compared to the 2-back minus 0-back condition on the mock 
day.  
Figure 3. Activation map for the Face-Name encoding task comparing the novel minus 
familiar faces condition for the mock day only.  
Figure 4. Activation map for the Face-Name encoding task comparing the novel minus 
familiar faces condition on the OGTT day compared to the novel minus familiar 
condition on the mock day.  
Figure 5. Performance measures (proportion of correct hits) for each N-back condition. 
There was a main effect of working memory on performance (F(3,15)=8.474, p=0.002). 
There was no main effect of drink (OGTT or mock) on performance (F(1,5)=1.404, 
p=0.289); or interaction between drink and working memory on performance 
(F(3,15)=0.272, p=0.845).  
Figure 6. Proportion of false alarms for each N-back condition in the OGTT compared to 
the mock day. There was a significant effect of working memory load on performance 
(F(3,15)=14.45, p<.0010). There was no main effect of drink on performance (F(1,5)=0, 
p=.996). There was no interaction between drink and working memory load on number 
false alarms (F(3,15)=0.692, p=0.571).  
Figure 7. Serum glucose levels (mg/dl) measured at four time points during the OGTT 
day compared to the mock day. There was no main effect of drink on glucose level 
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(F(1,5)=1.681, p=0.251). There was no main effect of time on glucose 
level(F(3,15)=1.245, p=0.329), nor was there an interaction between drink and time over 
the course 120 minutes (F(3,15)=0.621, p=0.612).  
Figure 8. Serum insulin levels (uu/mL) at four time points during the OGTT study day 
compared to the mock day.  There is a main effect of drink (F(1,5)=18.4, p=0.008) and 
time (F (3,15)=8.443, p=0.002). There was a significant interaction between drink and 
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Figure 6.  
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